Navigation Links
BioMedical Enterprises, Inc. (BME) Announces the Appointment of Kenneth I. Moch as President and Chief Executive Officer
Date:1/7/2009

SAN ANTONIO, Jan. 7 /PRNewswire/ -- BioMedical Enterprises, Inc. (BME), a cutting edge medical device company focused on the development of orthopaedic memory metal implants, announced today that it has appointed Kenneth I. Moch as its President and Chief Executive Officer. W. Casey Fox, PhD, P.E., BME's Founder, will become Chief Technology Officer and continue to focus his efforts on building BME's innovative product offerings.

BME specializes in nitinol implants that contract and compress bone after implantation, bringing bone ends together to promote bone union. These proprietary implants allow the surgeon to finely control the amount of compression and rate of force application generated on bones, thereby reducing fractures and stimulating bone healing.

"Ken is a proven leader who brings extensive senior management and operational experience to BME, as well as a shared strategic vision to create a leading medical device company," said Richard M. Johnston, Chairman of BME and Managing Member of Camden Partners Holdings, LLC.

Mr. Moch has served as the President of Euclidean Life Science Advisors, which provides strategic advisory services to life sciences companies, since early 2008. He previously was Managing Director, Healthcare Investment Banking at ThinkEquity Partners and Chairman, President and CEO of Alteon, Inc., a biotech company specializing in small molecule therapeutics for cardiovascular aging and diabetic complications. Mr. Moch earlier served as President and CEO of Biocyte Corporation, the cellular therapy company that pioneered the collection and commercial application of cord blood stem cells, and as a management consultant with McKinsey & Company, Inc. Mr. Moch holds a degree in biochemistry from Princeton University and an MBA from the Stanford Graduate School of Business.

"It is a privilege to be joining BME at this exciting time in the compan
'/>"/>

SOURCE BioMedical Enterprises, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. 5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes
2. Response Biomedical Corporation Announces Change of Executives
3. AutismActionPlan.org Launches Doctor-Driven Biomedical Autism Treatment Website
4. ASH Holds a Special Symposium to Interest High School Students in Biomedical Research
5. ASH Honors Speaker of the House Nancy Pelosi and NHLBI Deputy Director Susan Shurin, MD, for Their Public Service, Leadership, and Commitment to Biomedical Research
6. Response Biomedical Corporation Announces Initiation of Respiratory Syncytial Virus Infection Clinical Trial
7. Environmental Tectonics Corporations BioMedical Systems Division Announces Additional Sales of its Baramed Monoplace Chambers
8. Hepatitis C Therapeutic DNA Vaccine Delivered by Inovio Biomedical's Electroporation Technology Reduces Viral Load by Up to 99.7% : Clinical Data Presented at Annual Scientific Meeting of the American Association for the Study of Liver Diseases
9. Response Biomedical to Present at Rodman and Renshaw 10th Annual Healthcare Conference
10. Interview with Dr. Elisabeth Hager, CEO of Balan Biomedical, Inc., to Air Nationally on Sky Radio
11. Response Biomedical Closes $5.1 Million Financing

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2009)...ctors unaware the sleep disorder boosts urine prod... (HealthDay News) -- People who wake up during the...urological problem. Sleep apnea, a breathing-relat...study suggests that nighttime urination, or noctur...obstructive sleep apnea, a disorder in which soft ...
(Date:11/28/2009)...offenders were more likely to consider change afte... , , FRIDAY, Nov. 27 (HealthDay News) --...onsider why they should stop their dangerous behav...es, researchers have found. , The new study inc...hile-impaired convictions, who were randomly assig...
(Date:11/27/2009)... Biotech firm Replikins Ltd. tod...1N1 virus genomic data. It shows that the lethali...s.d. 4.5) during the virus,s current outbreak in t...his week of 2.0 (s.d. 0.1). The H1N1 infectivity c... Boston (PRWEB) November 27, 2009 -- Bio...
(Date:11/27/2009)..., KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire-Fi... SHMR ) ( "Shamir" ), a leading provider of innova...s market, announced today that its board of direct...regate amount of US$ 10 million (approximately NIS...esentative rate of exchange), or approximately US$...
(Date:11/27/2009)... Voyant Health™ announced ...) has licensed its TraumaCad Enterprise orthopedic...flow solution. , (PRWEB) ...d today that Spectrum Health (Grand Rapids, Michig...ic templating solution and its TraumaCad Extend wo...
Breaking Medicine News(10 mins):Health News:Sleep Apnea May Cause Nighttime Urination 2Health News:Sleep Apnea May Cause Nighttime Urination 3Health News:Drunk Drivers May Respond to Brief Motivational Interview 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3
...eism is still rampant in America, and many old peo...f the elderly, including helplessness and incompet...l, they are also unhealthy. Research has shown tha... in Psychological Science , a journal of the Asso...
...rch 10, 2009 -- Researchers at Washington Universi...otential indicator of Alzheimer,s disease to brain...nt. , Although their cognitive and neurological a...d reduced whole brain volumes, suggesting that Alz...
...rious side effects are found in latest test, study... News) -- A third-generation tissue-cultured small...port. , "The threat of smallpox bioterrorism has p...have raised obstacles to vaccination campaigns in ...
...hologists provide information on this potentially ...l Cancer Awareness Month , , NORTHFIELD, Ill., Ma...er among men and women in the United States, exclu...on and treatment could save your life or the life ...
...iversity of Minnesota researchers found that the u...r health policy initiative, has had little or no e...hers say it,s still too early to judge the effecti...The study, funded by the Agency for Health Quality...
...MFORD, Conn., March 10 Stamford-based Olympus Par...Holopack International Corp. from The Hansen Corpo... in Columbia, S.C., will immediately change its na...plastic container is molded, filled and sealed in ...
Other Medicine News:Health News:The perils of ageism 2Health News:Brain damage found in cognitively normal people with Alzheimer's marker 2Health News:Brain damage found in cognitively normal people with Alzheimer's marker 3Health News:Japanese Researchers Develop New Smallpox Vaccine 2Health News:Understand Colon Cancer with MyBiopsy.Org; Schedule a Screening Test at MyHealthTestReminder.Org 2Health News:Understand Colon Cancer with MyBiopsy.Org; Schedule a Screening Test at MyHealthTestReminder.Org 3Health News:U of Minnesota researchers examine the value of health information technology 2
(Date:11/28/2009)...ewswire/ -- Siemens Healthcare redefines producti...al imaging matrix) technology and with its new Dot...nologies are introduced in the new MAGNETOM ®...3T scanners at the 95th Scientific Assembly and An...America (RSNA) from November 29 to December 3 at M...
(Date:11/26/2009)... Africa, Nov. 26 The 2009 Frost &a...d in the Generic Pharmaceutical Market is presente...o: http://www.newscom.com/cgi-bin/prnh/20081117/F...he following criteria were used to benchmark Cipla...wth strategy and implementation, degree of innovat...
(Date:11/25/2009)...25 Pharmasset, Inc. (Nas...any committed to discovering, developing and comme...reported financial results for the fiscal year end...asset held $58.4 million in cash, cash equivalents...te and 2009 Highlights ,, RG7128 ,, Pha...
Breaking Medicine Technology:Siemens Introduces Its New Power Couple at RSNA 2009 2Siemens Introduces Its New Power Couple at RSNA 2009 3Siemens Introduces Its New Power Couple at RSNA 2009 4Siemens Introduces Its New Power Couple at RSNA 2009 5Siemens Introduces Its New Power Couple at RSNA 2009 6Siemens Introduces Its New Power Couple at RSNA 2009 7Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Increase in Thyroid Cancer Puzzles Experts 51611 1Increase in Thyroid Cancer Puzzles Experts 51611 2Julie Stav Reminds Hispanic Moms to Invest in Their Familys Wellness with Milk 21 51606 1Julie Stav Reminds Hispanic Moms to Invest in Their Familys Wellness with Milk 21 51606 2Julie Stav Reminds Hispanic Moms to Invest in Their Familys Wellness with Milk 21 51606 3Music 26 Medicine 3A Unique Collaboration Combines Performing Arts and Science 4722 1Music 26 Medicine 3A Unique Collaboration Combines Performing Arts and Science 4722 2Music 26 Medicine 3A Unique Collaboration Combines Performing Arts and Science 4722 3Music 26 Medicine 3A Unique Collaboration Combines Performing Arts and Science 4722 4
...tly improved sleep onset, sleep maintenance ... BRIDGEWATER, N.J., June 10 Sanofi-aventis,annou...bien CR(R) (zolpidem,tartrate extended-release) CI... in sleep onset, sleep maintenance and total sleep...mnia and major depressive disorder,(MDD) who were ...
...nt blood glucose lowering effect of SGLT2 ...ls, - Eight additional presentations highlight si...c disease targets utilizing antisense, SAN FRANCI...icals, Inc. (Nasdaq: ISIS ) announced today the p...ntisense drugs potently reduce levels,of sodium de...
Other Medicine Technology:Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 2Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 3Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 4Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder 5Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference 2Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference 3Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference 4Isis Highlights Robust Drug Portfolio for Diabetes and Obesity at ADA Conference 5
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: